3.35MMarket Cap-249P/E (TTM)
0.5088High0.4411Low164.49KVolume0.5080Open0.5669Pre Close77.70KTurnover2.69%Turnover RatioLossP/E (Static)7.38MShares10.648552wk High-0.79P/B2.78MFloat Cap0.438852wk Low--Dividend TTM6.11MShs Float503.2500Historical High--Div YieldTTM11.94%Amplitude0.4388Historical Low0.4720Avg Price1Lot Size
Alzamend Neuro Stock Forum
Alzamend Neuro Inc. has laid out plans to secure up to $25 million through a private placement of preferred shares, a strategic maneuver aimed at bolstering its financial stature and accelerating its mission against Alzheimer's disease. This move marks a pivotal moment for the biotechnology firm, emphasizing its relentless...
Alzamend Neuro Announces Termination of at-the-Market Equity Offering Program
$Intra-Cellular Therapies(ITCI.US)$ Phase 3
$Bristol-Myers Squibb(BMY.US)$ PDUFA
$Alzamend Neuro(ALZN.US)$ Phase 2
$Alzamend Neuro(ALZN.US)$ Phase 2a
No comment yet